Results 1 to 10 of about 1,584,246 (267)

Challenges and opportunities for the next generation of computational tumor models. [PDF]

PLoS Biol
Munn LL, Jain RK.
europepmc   +1 more source

Publisher Correction: Metabolic adaptations direct cell fate during tissue regeneration. [PDF]

Nature
Chaves-Perez A, Millman SE, Janaki-Raman S, Ho YJ, Hinterleitner C, Barthet VJA, Morris JP, Barriga FM, Reyes J, Kyaw A, Pasolli HA, Pe'er D, Thompson CB, Finley LWS, Cross JR, Lowe SW.   +15 more
europepmc   +1 more source

Mechanistic modeling suggests stroma-targeting antibody-drug conjugates as an alternative to cancer-targeting in cases of heterogeneous target exspression. [PDF]

PLoS Comput Biol
Wood NE, Cengiz A, Gao M, Ratushny AV, Straube R.   +4 more
europepmc   +1 more source

Network-based approach identifies key genes associated with tumor heterogeneity in HPV positive and negative head and neck cancer patients. [PDF]

Sci Rep
Patiyal S, Agrawal P.
europepmc   +1 more source

AI-Driven Polypharmacology in Small-Molecule Drug Discovery. [PDF]

Int J Mol Sci
Abdelsayed M.
europepmc   +1 more source

Editorial: Exploring small molecule probes: advancements and applications in pharmacological research. [PDF]

Front Pharmacol
Yeh IJ.
europepmc   +1 more source

Computational and experimental discovery of peptide inhibitors targeting survivin for therapeutic potential in cancer. [PDF]

Sci Rep
Ahmadi SF, Arab SS, Samadikhah H.
europepmc   +1 more source

Experimental models of pancreas cancer: what has been the impact for precision medicine? [PDF]

J Clin Invest
Pantazopoulou V, Kubota CS, Ogawa S, Gulay KCM, Lin X, Song H, Weitz JR, Tiriac H, Lowy AM, Engle DD.   +9 more
europepmc   +1 more source

Omics datasets can bridge the gap between tumor biology and patient care. [PDF]

PLoS Biol
Huang JT, Dai LJ, Ma D, Shao ZM.
europepmc   +1 more source

Editorial: Molecular chaperones and polyamines in disease. [PDF]

Front Mol Biosci
Makumire S, Chakafana G, Makhoba XH.
europepmc   +1 more source